Furthermore, metabolomics analysis specifically uncovered the altered energy supply and stress pathways responsible for MICA induction and HCC cell inhibition, giving a physiological explanation of the mechanism underlying the chemoimmunotherapeutic efficacy of HDACi. The gene discussed is MICA; the disease is hepatocellular carcinoma.